Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
5-aminolevulinic acid (ALA) is a clinically approved prodrug involved in intracellular Heme biosynthesis to produce the natural photosensitizer (PS) Protoporphyrin IX (PpIX). ALA based photodynamic therapy (PDT) has been used to treat various malignant and non-malignant diseases. However, natural AL...
Main Authors: | Liang Lou, Shizhe Zhou, Sijia Tan, Menghua Xiang, Wei Wang, Chuang Yuan, Liqian Gao, Qicai Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1137707/full |
Similar Items
-
Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer
by: Jakub Golab, et al.
Published: (2011-05-01) -
Treatment of cutaneous lichen planus with ALA-mediated topical photodynamic therapy
by: Zhi-Xia Fan, et al.
Published: (2015-01-01) -
Cathepsin B-Cleavable Polymeric Photosensitizer Prodrug for Selective Photodynamic Therapy: In Vitro Studies
by: Manish Jain, et al.
Published: (2022-04-01) -
Co-Delivery of Paclitaxel Prodrug, Gemcitabine and Porphine by Micelles for Pancreatic Cancer Treatment via Chemo-Photodynamic Combination Therapy
by: Qiwei Wu, et al.
Published: (2022-10-01) -
PHOTODYNAMIC THERAPY IN THE MANAGEMENT OF NONMELANOMA SKIN CANCERS
by: Nebojsa Krstic, et al.
Published: (2008-04-01)